Ataturk University   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Erzurum Turkey (1957)

Organization Overview

First Clinical Trial
2011
NCT01956955
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Ataturk University | Atatürk University | Ataturk University Anesthesiology and Reanimation | Ataturk University, Department of Anesthesiology and Reanimation | Ataturk University Faculty of Medicine | ATATURK UNIVERSITY FACULTY OF MEDICINE | Ataturk University Medical Faculty | Betul Zeynep Yildiz | Bugra Kerget | Faculty of Medicine, Ataturk University, Erzurum, Turkey | Health Sciences University Ataturk Chest Diseases and Chest Surgery Hospital | Izmir Ataturk Training and Research Hospital | Scientific Research Fund of Atatürk University

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Pain (Phase 4)

Colic (Phase 4)

Hypotension (Phase 3)

Lung Diseases, Obstructive (Phase 4)

Pain, Postoperative (Phase 4)

Postoperative Complications (Phase 3)

Postoperative Nausea and Vomiting (Phase 3)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Renal Colic (Phase 4)

Sciatica (Phase 4)

Spinal Diseases (Phase 4)

Vomiting (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 50
  • # of Trial APIs: 29